{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fpbc-at-easl-and-ddw-2025-NxjLJK9q","width":444,"version":"1.0","type":"rich","title":"Key PBC Studies From EASL and DDW 2025 ","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/f02cd2be-c010-49a7-85a7-ae51ae2e239b/100295-pbc-updates-mm3-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/a3cf14c7-663e-46d8-9255-b085fd86aa77\" height=\"200\" width=\"100%\" title=\"Key PBC Studies From EASL and DDW 2025 \" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, listen as Dr Palak Trivedi catches you up on the most recent developments in primary biliary cholangitis (PBC) treatment, discussing cutting-edge data on new and emerging agents and providing insight into how these updates may be integrated into your practice.  "}